VOYXACT
NDC 59148-400, sibeprenlimab, injection, from Otsuka America Pharmaceutical, Inc..
- Product NDC
- 59148-400
- Status
- Listed
- Labeler
- Otsuka America Pharmaceutical, Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761434
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59148-400 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SIBEPRENLIMAB200 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59148-400-75 | 59148040075 | 1 SYRINGE in 1 CARTON (59148-400-75) / 2 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c8a93b32-0676-4704-86dc-cb65f425c6e5
Use it
Look up 59148-400 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59148-400 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59148-400. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.